Company: NKLR
Filing Date: 2025-11-10
Form Type: S-1
Source: 0001213900-25-108246
Chunk: 235

Company: Terra Innovatum Global N.V.
Filing Date: 2025-11-10
Form: S-1
Chunk 235
---
 Company has not yet identified (“Business Combination”).

As of December 31, 2024,
the Company had not yet commenced operations. All activity for the period from May 10, 2023 (inception) through December 31, 2024 relates
to the Company’s formation and the initial public offering (the “Initial Public Offering”). The Company will not generate
any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company expects to generate
non-operating income in the form of interest and dividend income from investments held in trust, which proceeds were derived from the
Initial Public Offering. The Company has selected December 31 as its fiscal year end.

Financing

The registration statement
for the Company’s Initial Public Offering was declared effective on November 7, 2024. On November 8, 2024, the Company consummated
the Initial Public Offering of 23,000,000 units including 3,000,000 additional public units as the underwriters ‘over-allotment
option was exercised in full (the “Units” and, with respect to the shares of Class A ordinary shares included in the Units
being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $230,000,000 (see Note 3).

Simultaneously with the consummation
of the Initial Public Offering and the sale of the Units, the Company consummated the private placement (“Private Placement”)
of 422,500 units including 7,500 additional private placement units as the underwriters ‘over-allotment option was exercised in
full (the “Private Placement Units”) to GSR III Sponsor LLC (the “Sponsor”), at a price of $10.00 per Private
Placement Unit, generating total proceeds of $4,225,000, which is described in Note 4. This amount from the sale of the Private Placement
Units are added to the net proceeds from the Initial Public Offering held in the Trust Account. The proceeds received from the sale of
the Private Placement Units held in the Trust Account was used partially to pay some general and administrative expenses.

Transaction costs amounted
to $11,084,352, consisting of $975,000 of cash underwriting fees, $9,200,000 of deferred underwriting fees which will be paid on the consummation
of initial Business Combination, and $909,352 of other offering costs.

Upon the closing of the